Drug intelligence / Profile preview

Soliprin

Development stage
Unknown
Lead developer
Unigen
Modality
Small Molecules
Administration
Topical
01

Overview

Soliprin is a patented and proprietary botanical blend cosmeceutical ingredient developed by Unigen, Inc. for cosmetic and personal care applications. It is composed of two plant extracts identified through a high-throughput screening of over 1,200 botanicals for their ability to mitigate ultraviolet (UV) damage and neutralize environmental toxins. Soliprin functions as a broad-spectrum anti-inflammatory and potent antioxidant, boasting an Oxygen Radical Absorbance Capacity (ORAC) value exceeding 102,000. Its biological activity is characterized by the modulation of prostaglandin and leukotriene pathways and the down-regulation of cytokine gene expression. Clinically, Soliprin has been shown to reduce UV-induced erythema and increase the Minimum Erythema Dosage (MED) in human subjects. It is typically incorporated into topical skin care formulations at concentrations of 0.5% to 1.5% to combat oxidative stress and support healthy skin aging.

Brand names
Soliprin
Other names
Soliprin™
02

Targets

COX15-LOX (Lysyl Oxidase)

Beyond the preview

Go deeper on Soliprin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Soliprin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call